ReviewIndian journal of microbiology2025
Analysis of Preferred Codon Usage in the ZIKA Virus Genome and Their Implications for Genome Evolution and Vaccine Design.
Review in Indian journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Zika virus and its deadly infectious status is a major concern to the world and the scientific community is trying to tackle the problem. The variability in the genomic material of the various isolates from different geographical locations put forward a major hurdle in designing effective therapeutics against the evolving strains. The time and resources utilized for the therapeutic development against this virus and its efficacy against viral infection inhibition are also concerning. Therefore, in the present study we have opted for a computational approach to first identify the significant markers within the genomes of ZV from India, Africa, and South America origin and employ relative synonymous codon usage and host adaptation-based approaches. The homology observed between these strains in their envelope protein suggests this protein can be utilized for vaccine development upon in vitro validations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.